Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?
Severe refractory asthma is characterized by a higher risk of asthma-related symptoms, morbidities, and exacerbations. This disease also determines much greater healthcare costs and deterioration in health-related quality of life (HR-QoL). Another concern, which is currently much discussed, is the h...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2019-04-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/efficacy-and-steroid-sparing-effect-of-benralizumab:-has-it-an-advantage-over-its-competitors? |